SURGIFLO

Clinical Indication

Surgical sites as an adjunct to hemostasis when control of bleeding by ligature or conventional methods is ineffective is impractical

Date of classification

November 2022

Red

Medicines which should be prescribed only in a specialist setting usually within a secondary or tertiary care service. NB: Some highly specialised RED medicines e.g. injectable treatments for cancer are not included on the LLR APC website list.